Reported figures and Equlion model projections for the next 5 years.
ROE
+149.6 pt
Company
Sector average
ROA
-3.9 pt
Company
Total Assets
-7.2%
Company
Sector average (own scale)
Net Income
-0.3%
Company
Sector average (own scale)
Detailed data
USD
Amounts in USD; stock price per share. Values that are missing or fail Equlion's automated data-quality checks are shown as “-”. Projections are model estimates, not investment advice.
Want the full financial forecast report for Dogwood Therapeutics, Inc.? It covers the balance sheet, income statement, cash flow and Equlion model projections.